华森制药：股东刘小英计划减持公司股份不超过约1253万股

Group 1 - The core point of the article is that Liu Xiaoying plans to reduce her shareholding in Huason Pharmaceutical, with specific limits on the number of shares to be sold [1] - Liu Xiaoying holds approximately 35.89 million shares of the company and intends to sell up to about 4.18 million shares through centralized bidding, which is no more than 1% of the total share capital [1] - Additionally, she plans to sell up to about 8.35 million shares through block trading, representing no more than 2% of the total share capital, leading to a total potential reduction of up to approximately 12.53 million shares, or 3% of the total share capital [1]